1. Home
  2. IMAB vs SLNG Comparison

IMAB vs SLNG Comparison

Compare IMAB & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • SLNG
  • Stock Information
  • Founded
  • IMAB 2014
  • SLNG 2013
  • Country
  • IMAB United States
  • SLNG United States
  • Employees
  • IMAB N/A
  • SLNG N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • SLNG Oil/Gas Transmission
  • Sector
  • IMAB Health Care
  • SLNG Utilities
  • Exchange
  • IMAB Nasdaq
  • SLNG Nasdaq
  • Market Cap
  • IMAB 73.9M
  • SLNG 81.1M
  • IPO Year
  • IMAB 2020
  • SLNG N/A
  • Fundamental
  • Price
  • IMAB $0.89
  • SLNG $5.24
  • Analyst Decision
  • IMAB Strong Buy
  • SLNG Strong Buy
  • Analyst Count
  • IMAB 2
  • SLNG 1
  • Target Price
  • IMAB $5.50
  • SLNG $12.00
  • AVG Volume (30 Days)
  • IMAB 220.3K
  • SLNG 19.8K
  • Earning Date
  • IMAB 04-03-2025
  • SLNG 05-07-2025
  • Dividend Yield
  • IMAB N/A
  • SLNG N/A
  • EPS Growth
  • IMAB N/A
  • SLNG 3561.99
  • EPS
  • IMAB N/A
  • SLNG 0.25
  • Revenue
  • IMAB N/A
  • SLNG $73,293,000.00
  • Revenue This Year
  • IMAB N/A
  • SLNG $8.97
  • Revenue Next Year
  • IMAB N/A
  • SLNG $6.90
  • P/E Ratio
  • IMAB N/A
  • SLNG $23.80
  • Revenue Growth
  • IMAB N/A
  • SLNG 0.24
  • 52 Week Low
  • IMAB $0.60
  • SLNG $3.71
  • 52 Week High
  • IMAB $2.00
  • SLNG $8.28
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 53.91
  • SLNG 66.40
  • Support Level
  • IMAB $0.81
  • SLNG $5.76
  • Resistance Level
  • IMAB $0.97
  • SLNG $5.95
  • Average True Range (ATR)
  • IMAB 0.06
  • SLNG 0.35
  • MACD
  • IMAB 0.01
  • SLNG 0.14
  • Stochastic Oscillator
  • IMAB 54.94
  • SLNG 94.27

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

Share on Social Networks: